Teladoc Health, Inc. (NYSE:TDOC) Q1 2023 Earnings Conference Call April 26, 2023 4:30 PM ET
Company Participants
Patrick Feeley – Head of Investor Relations
Jason Gorevic – Chief Executive Officer
Mala Murthy – Chief Financial Officer
Conference Call Participants
Lisa Gill – J.P. Morgan
Sandy Draper – Guggenheim
Jack Senft – William Blair
Stephanie Davis – SVB
Jailendra Singh – Truist
Daniel Grosslight – Citi
Richard Close – Canaccord
Jessica Tassan – Piper Sandler
Sean Dodge – RBC Capital Markets
Allen Lutz – Bank of America
Operator
Hello, and welcome to the Teladoc Health Q1 2023 Earnings Conference Call. My name is Alex, and I'll be coordinating the call today. [Operator Instructions]
I'll now hand over to your host, Patrick Feeley, Head of Investor Relations to begin. Please go ahead.
Patrick Feeley
Thank you, and good afternoon. Today, after the market closed, we issued a press release announcing our first quarter 2023 financial results. This press release and the accompanying slide presentation are available on the Investor Relations section of the teladochealth.com website. On this call to discuss the results are Jason Gorevic, Chief Executive Officer; and Mala Murthy, Chief Financial Officer. During this call, we will also discuss our second quarter and full year 2023 outlook, and our prepared remarks will be followed by a question-and-answer session.
Please note that we'll be discussing certain non-GAAP financial measures that we believe are important in evaluating Teladoc Health's performance. Details on the relationship between these non-GAAP measures to the most comparable GAAP measures and reconciliations thereof can be found in the press release that is posted on our website. Also, please note that certain statements made during this call will be forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, uncertainties and other factors that could cause the actual results for Teladoc Health to differ materially from those expressed or implied on this call. For additional information, please refer to our cautionary statement in our press release and our filings with the SEC, all of which are available on our website.
I would now like to turn the call over to Jason.
Jason Gorevic
Thank you, Patrick. Good afternoon, and thanks for joining us. I'm pleased to report a strong start to the year across the business, meeting or exceeding all of our key financial and operating guidance in the first quarter. Today, we're raising the low end of our revenue and adjusted EBITDA guidance, a reflection of the quarter's strong results, and we'll speak to some of the key progress we've made in the first few months of the year.